CelebList
Kiran Mazumdar-Shaw

Is Kiran Mazumdar-Shaw A-List?

YesS

YesKiran Mazumdar-Shaw is above A-list, ranked S tier as an icon with generational cultural impact.

View full profile

Reached A-list in 2020

EY Entrepreneur of the Year

Ranking Timeline

1978D$0.1M

Founds Biocon

Kiran founds Biocon, initially focusing on industrial enzymes, starting her entrepreneurial journey. The early days were challenging with limited resources.

1989C$5M+$4.9M

Partners with Unilever

Biocon establishes a partnership with Unilever, enhancing its capabilities in biotechnology. This collaboration provides access to new markets.

2004B$200M+$195M

Biocon Goes Public

Biocon goes public, becoming the first biotechnology company in India to do so. The IPO generates significant capital for expansion.

2014B$800M+$600M

Othmer Gold Medal Recipient

Kiran receives the Othmer Gold Medal, recognizing her contributions to science and business. This prestigious award enhances her global reputation.

2020A$2B+$1.2B

EY Entrepreneur of the Year

Kiran is named the EY World Entrepreneur Of The Year, solidifying her status as a global business leader. The recognition boosts Biocon's profile.

2026S$2.5B+$500M

Biotechnology Pioneer

Kiran remains a leading figure in the biotechnology industry, with Biocon continuing to innovate and expand its global presence. She is celebrated for her contributions to healthcare.

Last updated: February 25, 2026